摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-formyl-2-(8-quinolinyl)benzonitrile | 565203-62-5

中文名称
——
中文别名
——
英文名称
4-formyl-2-(8-quinolinyl)benzonitrile
英文别名
4-Formyl-2-(quinolin-8-yl)benzonitrile;4-formyl-2-quinolin-8-ylbenzonitrile
4-formyl-2-(8-quinolinyl)benzonitrile化学式
CAS
565203-62-5
化学式
C17H10N2O
mdl
——
分子量
258.279
InChiKey
VJRPBHKOFDBYPD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    499.8±45.0 °C(Predicted)
  • 密度:
    1.29±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    53.8
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:fc7ae6d20df2dc902067e12f40568943
查看

反应信息

  • 作为反应物:
    描述:
    4-formyl-2-(8-quinolinyl)benzonitrile正丁基锂(1S,2R)-1-苯基-2-(1-吡咯烷基)-1-丙醇 作用下, 生成 、 4-[(R)-hydroxy-(3-methylimidazol-4-yl)methyl]-2-quinolin-8-ylbenzonitrile
    参考文献:
    名称:
    Enantioselective synthesis of the farnesyltransferase inhibitor, A-345665.0
    摘要:
    The stereoselective synthesis of A-345665.0 1, a novel farnesyl transferase inhibitor, is described. The key step involves a stereoselective addition of an imidazolyl Grignard reagent to aldehyde 8 in the presence of an external chiral auxiliary. Crystallization of the product as the dimeric zinc complex 12 facilitates the isolation of product in > 98:2 er. The biaryl linkage is formed by the use of a Suzuki coupling, employing boronic acid 4 prepared by the directed ortho-lithiation of benzonitrile 6. The overall yield for the six step sequence is 21%. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2006.10.008
  • 作为产物:
    描述:
    4-(二乙氧基甲基)苯甲腈 在 palladium diacetate 、 potassium fluoride 、 硼酸三异丙酯 、 2,2,6,6-tetramethylpiperidinyl-lithium 、 2-(二环己基膦基)联苯 作用下, 以 甲醇甲苯 为溶剂, 生成 4-formyl-2-(8-quinolinyl)benzonitrile
    参考文献:
    名称:
    Enantioselective synthesis of the farnesyltransferase inhibitor, A-345665.0
    摘要:
    The stereoselective synthesis of A-345665.0 1, a novel farnesyl transferase inhibitor, is described. The key step involves a stereoselective addition of an imidazolyl Grignard reagent to aldehyde 8 in the presence of an external chiral auxiliary. Crystallization of the product as the dimeric zinc complex 12 facilitates the isolation of product in > 98:2 er. The biaryl linkage is formed by the use of a Suzuki coupling, employing boronic acid 4 prepared by the directed ortho-lithiation of benzonitrile 6. The overall yield for the six step sequence is 21%. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2006.10.008
点击查看最新优质反应信息

文献信息

  • Substituted phenyl farnesyltransferase inhibitors
    申请人:——
    公开号:US20020019527A1
    公开(公告)日:2002-02-14
    Compounds of formula (I) 1 or pharmaceutically acceptable salts thereof, inhibit farnesyltransferase. Methods for making the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.
    式(I)的化合物或其药学上可接受的盐,抑制法尼基转移酶。公开了制备这些化合物的方法,含有这些化合物的药物组合物,以及使用这些化合物进行治疗的方法。
  • SUBSTITUTED PHENYL FARNESYLTRANSFERASE INHIBITORS
    申请人:Abbott Laboratories
    公开号:EP1276726A2
    公开(公告)日:2003-01-22
  • [EN] SUBSTITUTED PHENYL FARNESYLTRANSFERASE INHIBITORS<br/>[FR] INHIBITEURS DE PHENYLE FARNESYLTRANSFERASE SUBSTITUES
    申请人:ABBOTT LAB
    公开号:WO2001081316A2
    公开(公告)日:2001-11-01
    Compounds of formula (I) or pharmaceutically acceptable salts thereof, inhibit farnesyltransferase. Methods for making the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.
  • Enantioselective synthesis of the farnesyltransferase inhibitor, A-345665.0
    作者:Michael J. Rozema、Michael Fickes、Maureen McLaughlin、Bridget Rohde、Todd McDermott
    DOI:10.1016/j.tetlet.2006.10.008
    日期:2006.12
    The stereoselective synthesis of A-345665.0 1, a novel farnesyl transferase inhibitor, is described. The key step involves a stereoselective addition of an imidazolyl Grignard reagent to aldehyde 8 in the presence of an external chiral auxiliary. Crystallization of the product as the dimeric zinc complex 12 facilitates the isolation of product in > 98:2 er. The biaryl linkage is formed by the use of a Suzuki coupling, employing boronic acid 4 prepared by the directed ortho-lithiation of benzonitrile 6. The overall yield for the six step sequence is 21%. (c) 2006 Elsevier Ltd. All rights reserved.
查看更多